Olivier Guillin

6.7k total citations
51 papers, 1.8k citations indexed

About

Olivier Guillin is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Olivier Guillin has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 13 papers in Cellular and Molecular Neuroscience and 11 papers in Neurology. Recurrent topics in Olivier Guillin's work include Neurotransmitter Receptor Influence on Behavior (9 papers), Schizophrenia research and treatment (8 papers) and Transcranial Magnetic Stimulation Studies (8 papers). Olivier Guillin is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (9 papers), Schizophrenia research and treatment (8 papers) and Transcranial Magnetic Stimulation Studies (8 papers). Olivier Guillin collaborates with scholars based in France, United States and South Africa. Olivier Guillin's co-authors include Pierre Sokoloff, Jorge Díaz, Marc Laruelle, Nathalie Griffon, Anissa Abi‐Dargham, Patrick Carroll, Jean‐Charles Schwartz, Erwan Bézard, Christian E. Gross and Bernard Le Foll and has published in prestigious journals such as Nature, Journal of Pharmacology and Experimental Therapeutics and Psychological Medicine.

In The Last Decade

Olivier Guillin

46 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Guillin France 17 1.0k 530 446 389 266 51 1.8k
Susanne Nikolaus Germany 22 956 0.9× 485 0.9× 422 0.9× 265 0.7× 340 1.3× 78 1.8k
Melissa L. Perreault Canada 22 1.3k 1.3× 978 1.8× 320 0.7× 231 0.6× 185 0.7× 59 2.0k
Roberta Zanardini Italy 27 657 0.6× 413 0.8× 395 0.9× 414 1.1× 195 0.7× 45 2.2k
Dieter Krell Germany 23 634 0.6× 297 0.6× 541 1.2× 361 0.9× 163 0.6× 44 1.7k
Sven Kroener United States 22 811 0.8× 478 0.9× 724 1.6× 150 0.4× 91 0.3× 36 1.7k
J.E. Kleinman United States 17 703 0.7× 484 0.9× 368 0.8× 355 0.9× 139 0.5× 31 1.4k
B. Bogerts Germany 23 647 0.6× 334 0.6× 801 1.8× 853 2.2× 155 0.6× 38 2.1k
Tanja Brigadski Germany 22 1.1k 1.0× 506 1.0× 333 0.7× 223 0.6× 134 0.5× 36 2.3k
T M Hyde United States 15 1.3k 1.2× 849 1.6× 647 1.5× 453 1.2× 89 0.3× 21 2.4k
Juan E. Belforte Argentina 18 1.1k 1.0× 601 1.1× 536 1.2× 103 0.3× 301 1.1× 26 1.7k

Countries citing papers authored by Olivier Guillin

Since Specialization
Citations

This map shows the geographic impact of Olivier Guillin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Guillin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Guillin more than expected).

Fields of papers citing papers by Olivier Guillin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Guillin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Guillin. The network helps show where Olivier Guillin may publish in the future.

Co-authorship network of co-authors of Olivier Guillin

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Guillin. A scholar is included among the top collaborators of Olivier Guillin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Guillin. Olivier Guillin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guillin, Olivier, et al.. (2024). One Train May Hide Another: Two Cases of Co-Occurring Primary Familial Brain Calcification and Alzheimer’s Disease. Journal of Molecular Neuroscience. 74(1). 2–2.
2.
Chastan, Nathalie, Najate Achamrah, Olivier Etard, et al.. (2024). Effects of repetitive transcranial magnetic stimulation of the right inferior parietal lobe on the body image perception in anorexia nervosa: A pilot randomized controlled study. Brain and Behavior. 14(7). e3617–e3617. 1 indexed citations
3.
Leroux, Elise, Robin de Florès, Rémy Morello, et al.. (2024). Effects of web-based adapted physical activity on hippocampal plasticity, cardiorespiratory fitness, symptoms, and cardiometabolic markers in patients with schizophrenia: a randomized, controlled study. European Archives of Psychiatry and Clinical Neuroscience. 274(6). 1245–1263. 1 indexed citations
4.
Guillin, Olivier, et al.. (2023). Étude nationale française du profil des patients hospitalisés en unité pour malades difficiles. Annales Médico-psychologiques revue psychiatrique. 182(2). 104–114. 3 indexed citations
5.
Bouaziz, Noomane, Charles Laidi, Samuel Bulteau, et al.. (2023). Real world transcranial magnetic stimulation for major depression: A multisite, naturalistic, retrospective study. Journal of Affective Disorders. 326. 26–35. 15 indexed citations
6.
Fovet, Thomas, Marielle Wathelet, Mathilde Horn, et al.. (2023). Opening the black box of hospitalizations in French high-secure psychiatric forensic units. L Encéphale. 49(6). 645–648. 2 indexed citations
7.
Bulteau, Samuel, Olivier Bonnot, Norbert Winer, et al.. (2022). Efficacy and Safety of Transcranial Electric Stimulation during the Perinatal Period: A Systematic Literature Review and Three Case Reports. Journal of Clinical Medicine. 11(14). 4048–4048. 8 indexed citations
8.
9.
10.
Guillin, Olivier. (2020). Les antipsychotiques de la future décade. Bulletin de l Académie Nationale de Médecine. 204(9). 1043–1046. 1 indexed citations
11.
Duflot, Thomas, et al.. (2019). Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disorders. Drug Testing and Analysis. 11(9). 1453–1459. 3 indexed citations
12.
Maatoug, Redwan, Benoît Le Goff, Jean‐Yves Rotgé, et al.. (2019). Performance in delayed non-matching to sample task predicts the diagnosis of obsessive–compulsive disorder. Translational Psychiatry. 9(1). 338–338. 4 indexed citations
13.
Maltête, David, et al.. (2015). A manic episode with psychotic features improved by methylprednisolone in a patient with multiple sclerosis. General Hospital Psychiatry. 37(6). 621.e1–621.e2. 9 indexed citations
14.
Lambrey, Simon, et al.. (2011). Retrospective Review of Clozapine in the Treatment of Patients With Autism Spectrum Disorder and Severe Disruptive Behaviors. Journal of Clinical Psychopharmacology. 31(3). 341–344. 48 indexed citations
15.
Guillin, Olivier, Caroline Demily, & Florence Thibaut. (2007). Brain‐Derived Neurotrophic Factor in Schizophrenia and Its Relation With Dopamine. International review of neurobiology. 78. 377–395. 46 indexed citations
16.
Narendran, Rajesh, Mark Slifstein, Olivier Guillin, et al.. (2006). Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo. Synapse. 60(7). 485–495. 140 indexed citations
17.
Bézard, Erwan, Christian E. Gross, Olivier Guillin, et al.. (2006). The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders. CNS & Neurological Disorders - Drug Targets. 5(1). 25–43. 270 indexed citations
18.
Narendran, Rajesh, Dah‐Ren Hwang, Mark Slifstein, et al.. (2005). Measurement of the Proportion of D2 Receptors Configured in State of High Affinity for Agonists in Vivo: A Positron Emission Tomography Study Using [11C] N-Propyl-norapomorphine and [11C]Raclopride in Baboons. Journal of Pharmacology and Experimental Therapeutics. 315(1). 80–90. 49 indexed citations
19.
Jeanneteau, Freddy, Olivier Guillin, Jorge Díaz, Nathalie Griffon, & Pierre Sokoloff. (2004). GIPC Recruits GAIP (RGS19) To Attenuate Dopamine D2Receptor Signaling. Molecular Biology of the Cell. 15(11). 4926–4937. 60 indexed citations
20.
Sokoloff, Pierre, Olivier Guillin, Jorge Díaz, Patrick Carroll, & Nathalie Griffon. (2002). Brain-derived neurotrophic factor controls dopamine D3 receptor expression: Implications for neurodevelopmental psychiatric disorders. Neurotoxicity Research. 4(7-8). 671–678. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Nikolaus Breakdown of academic impact, for papers by Melissa L. Perreault Breakdown of academic impact, for papers by Roberta Zanardini Breakdown of academic impact, for papers by Dieter Krell Breakdown of academic impact, for papers by Sven Kroener Breakdown of academic impact, for papers by J.E. Kleinman Breakdown of academic impact, for papers by B. Bogerts Breakdown of academic impact, for papers by Tanja Brigadski Breakdown of academic impact, for papers by T M Hyde Breakdown of academic impact, for papers by Juan E. Belforte
Rankless by CCL
2026